Zobrazeno 1 - 10
of 72
pro vyhledávání: '"K Coeleveld"'
Autor:
E M van Helvoort, J Popov-Celeketic, N Eijkelkamp, K Coeleveld, M A Tryfonidou, C D Wijne, C E Hack, F P J G Lafeber, S C Mastbergen
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219587 (2019)
ObjectiveAn ideal disease modifying osteoarthritis drug (DMOAD) has chondroprotective, anti-inflammatory, and analgesic effects. This study describes the production and characterization of a canine IL4-10 fusion protein (IL4-10 FP) and evaluates its
Externí odkaz:
https://doaj.org/article/1b11265c96bc4c6c89a1c1f3cdda314d
Autor:
Lize F D van Vulpen, K. Coeleveld, Roger E. G. Schutgens, Astrid E Pulles, Floris P J G Lafeber, Simon C. Mastbergen
Publikováno v:
Haemophilia
Introduction Early intervention in the devastating process of haemophilic arthropathy (HA) is highly desirable, but no disease‐modifying therapy is currently available. Considering the pivotal role of iron in the development of HA, iron chelation i
Autor:
Sabine Versteeg, E.M. van Helvoort, Niels Eijkelkamp, Harrie Weinans, H.M. de Visser, J. Popov-Celeketic, Simon C. Mastbergen, K. Coeleveld, F.P.J.G. Lafeber
Publikováno v:
Cartilage
Objective Ideally, disease-modifying osteoarthritis (OA) drugs (DMOAD) should combine chondroprotective, anti-inflammatory, and analgesic effects in a single molecule. A fusion protein of interleukin-4 (IL-4) and IL-10 (IL4-10 FP) possesses these com
Autor:
Astrid E Pulles, Kirstine Roepstorff, K. Coeleveld, Floris P J G Lafeber, Roger E. G. Schutgens, Simon C. Mastbergen, Kristine Rothaus Christensen, Axel Kornerup Hansen, Kåre Kryger Vøls, Mads Kjelgaard-Hansen, Maj Petersen, Lize F D van Vulpen
Publikováno v:
Haemophilia
Pulles, A E, Vøls, K K, Christensen, K R, Coeleveld, K, Hansen, A K, van Vulpen, L F D, Petersen, M, Mastbergen, S C, Roepstorff, K, Schutgens, R E G, Kjelgaard-Hansen, M & Lafeber, F P J G 2020, ' Proteoglycan synthesis rate as a novel method to measure blood-induced cartilage degeneration in non-haemophilic and haemophilic rats ', Haemophilia, vol. 26, no. 3, pp. e88-e96 . https://doi.org/10.1111/hae.13969
Pulles, A E, Vøls, K K, Christensen, K R, Coeleveld, K, Hansen, A K, van Vulpen, L F D, Petersen, M, Mastbergen, S C, Roepstorff, K, Schutgens, R E G, Kjelgaard-Hansen, M & Lafeber, F P J G 2020, ' Proteoglycan synthesis rate as a novel method to measure blood-induced cartilage degeneration in non-haemophilic and haemophilic rats ', Haemophilia, vol. 26, no. 3, pp. e88-e96 . https://doi.org/10.1111/hae.13969
Introduction: Haemophilic animal models are used to study blood-induced cartilage damage, but quantitative and sensitive outcome measures are needed. Aim: To develop a novel quantitative method for detecting early cartilage degeneration in a haemophi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Huub M. de Visser, Mattie H.P. van Rijen, K. Coeleveld, Simon C. Mastbergen, Floris P J G Lafeber, Harrie Weinans
Publikováno v:
Journal of Orthopaedic Research. 35:496-505
Several experimental models of osteoarthritis in rats are used to study the pathophysiology of osteoarthritis. Many mechanically induced models have the limitation that permanent joint instability is induced by, for example, ligament transection or m
Autor:
J. Popov-Celeketic, M. Teunissen, K. Coeleveld, F.P.J.G. Lafeber, S.C. Mastbergen, Marianna A. Tryfonidou, Björn P. Meij
Publikováno v:
Annals of the Rheumatic Diseases. 79:242.1-242
Background:Knee joint distraction (KJD) is a validated joint-preserving treatment strategy for severe osteoarthritis (OA) that provides long-term clinical and structural improvement. Human trials and animal models indicate clear cartilage regeneratio
Autor:
EM Van Helvoort, F.P.J.G. Lafeber, S.C. Mastbergen, J. Popov-Celeketic, K. Coeleveld, Marianna A. Tryfonidou, C. D. Wijne, A. Doornenbal
Publikováno v:
FRIDAY, 15 JUNE 2018.
Background An ideal disease modifying osteoarthritis (OA) drug should have analgesic, chondroprotective and anti-inflammatory effects. A fusion protein of Interleukin 4 and 10 (IL4–10FP) might have these effects. Objectives This study evaluates the
Autor:
Mattie H.P. van Rijen, A.E. Kozijn, Harrie Weinans, Floris P J G Lafeber, Simon C. Mastbergen, Huub M. de Visser, Behdad Pouran, K. Coeleveld
Publikováno v:
Journal of Orthopaedic Research.
Evidence is growing for the existence of an obesity-related phenotype of osteoarthritis in which low-grade inflammation and a disturbed metabolic profile play a role. The contribution of an obesity-induced metabolic dysbalance to the progression of t
Autor:
Marianna A. Tryfonidou, J. Popov-Celeketic, K. Coeleveld, F.P.J.G. Lafeber, EM Van Helvoort, S.C. Mastbergen
Publikováno v:
Poster Presentations.
Background Ideally a disease modifying osteoarthritis drug (DMOAD) combines treatment for pain, tissue damage and inflammation, all in one molecule. Intra-articular application of a DMOAD brings additional value to treatment for two reasons, (i) lowe